zolpidem has been researched along with Autistic Disorder in 3 studies
Zolpidem: An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.
zolpidem : An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.
Autistic Disorder: A disorder beginning in childhood. It is marked by the presence of markedly abnormal or impaired development in social interaction and communication and a markedly restricted repertoire of activity and interest. Manifestations of the disorder vary greatly depending on the developmental level and chronological age of the individual. (DSM-V)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The presentation of catatonia in autism and the use of ECT in children are discussed, and the available literature reviewed." | 1.30 | Catatonia, autism, and ECT. ( Bates, GD; Bentham, P; Murali, V; Zaw, FK, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, S | 1 |
| Tai, C | 1 |
| Jones, CJ | 1 |
| Scheuer, T | 1 |
| Catterall, WA | 1 |
| Zaw, ZF | 1 |
| Bates, GD | 2 |
| Zaw, FK | 1 |
| Murali, V | 1 |
| Bentham, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Use of Electroconvulsive Therapy to Treat Self-Injurious Behavior in Adults With Autism Spectrum Disorders[NCT03980366] | 1 participants (Actual) | Interventional | 2019-03-15 | Terminated (stopped due to We have not obtained additional subjects and chose to terminate/close this study.) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 other studies available for zolpidem and Autistic Disorder
| Article | Year |
|---|---|
Enhancement of inhibitory neurotransmission by GABAA receptors having α2,3-subunits ameliorates behavioral deficits in a mouse model of autism.
Topics: Animals; Autistic Disorder; Behavior, Animal; Benzodiazepines; Brain; Disease Models, Animal; Fluoro | 2014 |
Replication of zolpidem test for catatonia in an adolescent.
Topics: Adolescent; Autistic Disorder; Catatonia; Humans; Hypnotics and Sedatives; Male; Pyridines; Zolpidem | 1997 |
Catatonia, autism, and ECT.
Topics: Adolescent; Autistic Disorder; Catatonia; Combined Modality Therapy; Depressive Disorder; Disease Pr | 1999 |